Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
CXM (AMEX: CXM)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Premium News
Press Releases
SEC
PicksThatMove.com Announces Investment Opinion on Oro Silver Resources, Alcoa Inc., Cardium Therapeutics Inc., Altima Resources Ltd. and Citadel Broadcasting Corporation
Nov 10, 2009 04:00 PM |
AA
,
CXM
Cardium Reports on Third Quarter 2009 Financial Results and Recent Developments
Nov 10, 2009 09:02 AM |
CXM
,
PHG
Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds
Nov 02, 2009 10:30 AM |
CXM
PicksThatMove.com Announces Investment Opinion on Cardium Therapeutics Inc., NuLoch Resources Inc., Power 3 Medical Products Inc., DIRECTV Group Inc. Encore Renaissance Resources
Oct 30, 2009 06:03 PM |
CXM
,
DTV
Cardium Completes $6.0 Million Registered Direct Offering
Oct 20, 2009 03:40 PM |
CXM
Cardium Announces $6.0 Million Registered Direct Offering
Oct 15, 2009 09:15 AM |
CXM
Positive Findings from Excellarate(TM) Phase 1/2 Clinical Study Published in Journal of Wound Repair and Regeneration
Oct 15, 2009 09:01 AM |
CXM
Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers
Oct 14, 2009 09:04 AM |
CXM
Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program
Oct 14, 2009 09:02 AM |
CXM
Skymark Research Initiates Independent Research Coverage On Cardium Therapeutics, Inc.
Oct 09, 2009 09:03 AM |
CXM
More..
Members of Artes Medical Face Suit
Sep 11, 2008 10:53 AM |
ARTE
,
CXM
,
TRC
More..
Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
Aug 27, 2009 10:01 AM |
CXM
Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
Aug 25, 2009 03:09 PM |
CXM
Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
Aug 11, 2009 01:56 PM |
CXM
,
PHG
Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
Aug 11, 2009 09:59 AM |
CXM
,
PHG
Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
Jul 30, 2009 09:02 AM |
CXM
Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications
Jul 28, 2009 09:07 AM |
CXM
Cardium Regains Listing Compliance With NYSE Amex
Jul 27, 2009 10:00 AM |
CXM
,
PHG
Cardium Completes Sale of InnerCool Therapies Business to Royal Philips Electronics
Jul 24, 2009 09:54 AM |
CXM
,
PHG
Philips Expands Emergency Healthcare Offering With Acquisition of InnerCool Therapies, a Leader in Body Temperature Management
Jul 15, 2009 08:05 AM |
CXM
,
PHG
Cardium's InnerCool Therapies Business to Be Acquired By Royal Philips Electronics
Jul 15, 2009 08:02 AM |
CXM
,
PHG
More..
Form 4 Rubanyi Gabor M For: Jun 11 (10K)
Jun 15, 2009 05:43 PM
Form 4 Leitch Andrew M For: Mar 09 (10K)
Mar 18, 2009 02:46 PM
Form 4 Otremba Lon E For: Mar 09 (10K)
Mar 17, 2009 07:16 PM
Form 4 Cardium Therapeutics, For: Mar 09 Filed by: LEWIS GERALD J (10K)
Mar 17, 2009 07:16 PM
Form 4 MULROY DENNIS For: Mar 09 (10K)
Mar 17, 2009 07:15 PM
Form 4 Gabrielson Edward W For: Mar 09 (10K)
Mar 17, 2009 07:15 PM
Form 4 Cardium Therapeutics, For: Mar 09 Filed by: HUTCHISON MURRAY H (10K)
Mar 17, 2009 07:13 PM
Form 4 SIMON RONALD I For: Jan 22 (10K)
Feb 02, 2009 07:12 PM
Form 4 Cardium Therapeutics, For: Nov 05 Filed by: REINHARD CHRISTOPHER J (10K)
Nov 12, 2008 09:13 PM
Form 4 Cardium Therapeutics, For: Nov 05 Filed by: Dylan Tyler Michael (10K)
Nov 12, 2008 09:10 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Bull
Bear
1
0
Avg. Long Term
Bull
Bear
1
0
Avg. Grade
More Details
Share Performance
Period
CXM
Compare to S&P
YTD
-20.00 %
-33.80 %
4 Weeks
-13.04 %
-17.45 %
12 Weeks
-68.25 %
-70.44 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
36.36 %
EPS Growth in Last Year:
46.15 %
Sales Growth in Last Quarter:
3,271.43 %
Sales Growth in Last Quarter:
-59.66 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
